Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
PEPG PepGen
- 6.350
- +0.380+6.37%
Close Dec 3 16:00 ET
- 6.350
- 0.0000.00%
Post 20:01 ET
206.98MMarket Cap-2130P/E (TTM)
6.850High6.080Low278.07KVolume6.430Open5.970Pre Close1.81MTurnover1.80%Turnover RatioLossP/E (Static)32.60MShares19.29852wk High1.51P/B98.32MFloat Cap4.00052wk Low--Dividend TTM15.48MShs Float20.000Historical High--Div YieldTTM12.90%Amplitude3.720Historical Low6.496Avg Price1Lot Size
About PepGen Company
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Company Profile
SymbolPEPG
Company NamePepGen
Listing DateMay 6, 2022
Issue Price12.00
Founded2018
CEOMr. James McArthur, PhD
MarketNASDAQ
Employees64
Fiscal Year Ends12-31
Address321 Harrison Avenue,8th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-781-797-0979
Websitehttp://pepgen.com
Company Executives
- Name
- Position
- Salary
- James McArthur, PhD
- President, Chief Executive Officer and Director
- 3.43M
- Noel Donnelly, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 1.97M
- Dr. Michelle L. Mellion, M.D.
- Senior Vice President, Clinical Development
- 1.41M
- Dr. Niels Svenstrup, PhD
- Senior Vice President, Chemistry, Manufacturing and Control
- --
- Laurie B. Keating, J.D.
- Chairman of the Board
- 154.82K
- Habib Joseph Dable
- Independent Director
- 90.24K
- Heidi Henson, C.P.A.
- Independent Director
- 123.32K
- Dr. Howard Mayer, M.D.
- Independent Director
- 64.16K
- Mary Beth DeLena, J.D.
- General Counsel and Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
